A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache
Botulinum toxin type-A (BTX-A) injection for treating chronic migraine (CM) has developed into a new technique covering distinct injection points in the head and neck regions. The postulated analgesic mechanism implies that the injection should be administered to sensory nerves rather than to muscle...
Main Authors: | Young-gun Kim, Jung-Hee Bae, Hyeyun Kim, Shuu-Jiun Wang, Seong Taek Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/4/214 |
Similar Items
-
Botulinum Toxin in Treatment of Frey Syndrome - a Brief Report
by: Abraham Sonny, et al.
Published: (2008-01-01) -
Botulinum Toxin Type-A (Botulax<sup>®</sup>) Treatment in Patients with Intractable Chronic Occipital Neuralgia: A Pilot Study
by: Hyeyun Kim, et al.
Published: (2021-05-01) -
Botulinum Toxin in the Treatment of Headache
by: Werner J. Becker
Published: (2020-12-01) -
Effective Botulinum Toxin Injection Guide for Treatment of Temporal Headache
by: You-Jin Choi, et al.
Published: (2016-09-01) -
The Comparison of the Effects of Two Botulinum Toxin A Injection Methods, Follow the Pain and Fixed-site Fixed-dose, on Improving the Quality of Life and Headaches in Patients with Chronic Migraine: A Preliminary Randomized Clinical Trial
by: Hossein Salehi, et al.
Published: (2020-12-01)